StockData
Replimune Group, Inc. logo

Replimune Group, Inc. (REPL) stock

REPLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 6, 2026Score 1/30
$21.78−1.50 (-6.44%)

Close on Nov 11, 2026Market cap $2.06BP/E –Yield –

Replimune statistics

67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 2, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$2.06B
$282.97M
Enterprise Value
$1.86B
$154.96M
PB Ratio
10.08
2.17
P/TBV Ratio
10.08
2.39

Share statisticsIndustry

Shares Change (YoY)
8.93%
10.9%
Shares Change (QoQ)
12.9%
0.51%
Float
81M
49M
Shares Held by Insiders
14.7%
11.6%
Shares Held by Institutions
100.7%
56.4%

Short sellingIndustry

Short Interest
25M
–
Short Interest Change
6.23%
-0.76%
Short % of Float
30.4%
9.06%
Short % of Shares Outstanding
26.0%
6.38%
Days to Cover
8.31
5.16

Stock price statisticsIndustry

52-Week High
$23.54
–
52-Week Low
$1.50
–
20-Day Moving Average
$16.33
–
50-Day Moving Average
$14.51
–
200-Day Moving Average
$9.85
–
Average True Range (14)
$1.31
–
Price Change (1 Week)
5.27%
-0.50%
Price Change (1 Month)
79.9%
-0.33%
Price Change (3 Months)
43.4%
-17.2%
Price Change (6 Months)
310.9%
-20.1%
Price Change (YTD)
124.1%
-20.1%
Price Change (1 Year)
150.1%
-19.3%
Price Change (3 Years)
96.0%
-23.4%
Price Change (5 Years)
-34.9%
-76.4%
Average Volume (10 Days)
4M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
4M
–
Relative Volume
0.80
0.73
Relative Strength Index (14)
72.2
47.6
Volatility (1 Year)
187.6%
80.2%
Beta (5 Years)
0.65
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-115.8%
-51.3%
Return on Assets (ROA)
-71.0%
-40.3%
Return on Capital Employed (ROCE)
-82.1%
-37.7%

Financial positionIndustry

Current Ratio
7.11
3.30
Quick Ratio
6.76
2.37
Debt / Equity
0.49
0.49
Interest Coverage
-30.18
-6.27

EfficiencyIndustry

Profits Per Employee
-$582.87K
-$680.86K
Employee Count
465
75
WACC
8.07%
10.1%

Income statement (TTM)Industry

Operating Income
-$269.73M
-$20.20M
Net Income
-$271.03M
-$21.57M
EBITDA
-$266.43M
-$16.36M
EPS (Diluted)
-$2.80
-$0.77

Balance sheetIndustry

Total Debt
$99.77M
$118.49M
Net Cash (Debt)
$208.07M
$16.31M
Net Cash Per Share
$2.19
$0.70
Equity (Book Value)
$204.78M
$53.12M
Book Value Per Share
$2.16
$1.49
Tangible Book Value
$204.78M
$26.11M
Working Capital
$278.48M
$77.59M

Cash flow (TTM)Industry

Operating Cash Flow
-$245.55M
-$12.07M
Capital Expenditures
-$223.00K
-$939.00K
Free Cash Flow
-$245.77M
-$18.37M
FCF Per Share
-$2.59
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-13.1%
-19.8%
FCF Yield
-11.9%
-8.81%

Taxes and interestIndustry

Interest Expense
$8.94M
$2.98M

Scores and fair valueIndustry

Altman Z-Score
0.63
0.28
Piotroski F-Score
0
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodREPLS&P 500DifferenceREPL per yearS&P 500 per year
1 month+62.3%-2.4%+64.7 pts
3 months+59.6%-1.2%+60.7 pts
Year to date+124.1%+12.3%+111.8 pts
1 year+138.6%+12.4%+126.1 pts
3 years+96.0%+78.8%+17.2 pts+25.2%+21.4%
5 years-35.4%+75.2%−110.6 pts-8.4%+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

25M REPL shares were sold short on Oct 30, 2026, up 6.2% from the previous report, or 30.42% of the shares available to trade. At recent volumes it would take 8.3 days to buy them back. Over the last 20 sessions, 52.4% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202624,609,876+6.2%2,959,9388.3
Oct 15, 202623,165,699+0.2%1,824,71412.7
Sep 30, 202623,128,025+1.6%2,136,19310.8
Sep 15, 202622,754,597-3.3%2,042,81411.1
Aug 31, 202623,519,650-5.4%2,654,2098.9
Aug 14, 202624,866,611-9.7%6,282,2984.0
Jul 31, 202627,540,626+16.4%8,449,5263.3
Jul 15, 202623,654,362-0.1%2,504,9989.4
Jun 30, 202623,666,879+3.4%3,717,9126.4
Jun 15, 202622,885,091-11.8%4,731,8544.8
May 29, 202625,954,343+9.7%8,826,7292.9
May 15, 202623,657,005+11.8%8,360,3682.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?